文献速递消化道肿瘤放疗放疗物理与技术

局部晚期直肠癌术前放化疗联合深部区域热疗的前瞻性II期试验

Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial.
PubMed 文献 · Radiother Oncol · 2021-03-17

该前瞻性II期试验纳入78例局部晚期直肠癌患者,术前接受5-氟尿嘧啶为基础的放化疗(50.4 Gy/28次)联合每周两次深部区域热疗。主要终点pCR为14%,3年OS、DFS、LC、DC分别为94%、81%、96%、87%,热疗可行且未影响标准治疗。

要点

  • 77%患者完成至少8次热疗,热疗可行且未损害放化疗依从性。
  • pCR率14%,50%患者达到Dworak 3或4级退缩。
  • 热疗累积温度较高者肿瘤退缩更明显。

核心结论

  • 深部区域热疗在局部晚期直肠癌术前放化疗中可行,未影响标准治疗,并取得有前景的长期肿瘤学结局和生活质量。

研究设计与样本

  • 前瞻性II期试验,2012年至2017年招募78例局部晚期直肠癌患者,中位随访54个月,研究注册号NCT02353858。

主要发现

  • pCR率为14%,50%患者达到Dworak 4或Dworak 3级退缩。
  • 3年OS、DFS、LC、DC估计值分别为94%、81%、96%、87%。
  • 热疗相关累积温度较高的患者肿瘤退缩更强。
  • 基于EORTC-QLQ-C30的总体健康状况与一般人群数据相当。

关键数值与推荐

  • 放疗依从性99%,91%患者完成两周期化疗,77%患者接受至少8次热疗。
  • 放疗结束至手术的中位时间为6.7周。
  • 60%患者基于MRI显示直肠系膜筋膜受累或受威胁。

临床怎么用

  • 深部区域热疗可作为局部晚期直肠癌术前放化疗的可行联合手段,不损害标准治疗实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The goal of the present study was to investigate the effect of deep regional hyperthermia on early and long-term oncological outcomes in the context of preoperative radiochemotherapy in rectal cancer. METHODS: In this prospective phase II trial, patients with locally advanced rectal cancer were treated with 5-fluorouracil based preoperative radiochemotherapy with 50.4 Gy in 28 fractions. Deep regional hyperthermia was scheduled twice weekly. Pathological tumor regression was scored according to the Dworak regression system. The primary endpoint was pathological complete response (pCR). Further endpoints were local control (LC), distant control (DC), disease-free survival (DFS) and overall survival (OS). Hyperthermia was defined as feasible if 70% of patients received at least eight treatments. Quality of life was assessed at follow-up by the EORTC-QLQ-C30 and QLQ-CR29 questionnaires. Time to event data was analyzed according to Kaplan-Meier based on first-events. The study was registered on clinicaltrials.gov (NCT02353858). RESULTS: From 2012 until 2017, 78 patients were recruited. Median follow-up was 54 months. Based on magnetic resonance imaging, the mesorectal fascia was involved or threatened in 60% of the patients. Compliance with radiotherapy was 99%, 91% received both cycles of chemotherapy and 77% had eight or more hyperthermia treatments. Median time from the end of radiotherapy to surgery was 6.7 weeks. A pathological complete response was reported in 14% of the patients, 50% had either Dworak 4 (complete regression) or Dworak 3 regression (scattered tumor cells only). Three year estimates for OS, DFS, LC and DC were 94%, 81%, 96% and 87%. Patients with higher hyperthermia related cumulative temperatures showed stronger tumor regression. Global health status based on EORTC-QLQ-C30 was comparable with data from the general population. CONCLUSION: Deep regional hyperthermia was feasible, did not compromise standard treatments and resulted in promising long-term oncological outcomes and QoL.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Gani C, Lamprecht U, Ziegler A, et al. Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial. Radiother Oncol. 2021. PMID: 33741467. doi:10.1016/j.radonc.2021.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。